Health Cor Management, L.P. Revance Therapeutics, Inc. Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$14.33 - $28.47 $19.4 Million - $38.5 Million	-1,353,498 Reduced 95.45%	64,590 $1.74 Million
Q2 2022 Aug 15, 2022	SELL	$11.52 - $20.4 $61,482 - $108,874	-5,337 Reduced 0.37%	1,418,088 $19.6 Million
Q1 2022 May 16, 2022	SELL	$12.36 - $20.31 $326,427 - $536,387	-26,410 Reduced 1.82%	1,423,425 $27.8 Million
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $17 Million - $38.1 Million	1,368,335 Added 1678.94%	1,449,835 $23.7 Million
Q3 2021 Nov 15, 2021	BUY	$25.78 - $33.21 $2.1 Million - $2.71 Million	81,500 New	81,500 $2.27 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.